UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy

Multiple sclerosis, 2021-09, Vol.27 (10), p.1620-1623

2021

Volltextzugriff (PDF)

A low-fat diet improves fatigue in multiple sclerosis: Results from a randomized controlled trial

Multiple sclerosis, 2023-11, Vol.29 (13), p.1659-1675

2023

Volltextzugriff (PDF)

Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial

Multiple sclerosis and related disorders, 2016-09, Vol.9, p.80-90

2016

Volltextzugriff (PDF)

Complementary and Alternative Medical Therapies in Multiple Sclerosis–The American Academy of Neurology Guidelines: A Commentary

Clinical therapeutics, 2014-12, Vol.36 (12), p.1972-1978

2014

Volltextzugriff (PDF)

Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling

PloS one, 2010-09, Vol.5 (9), p.e13058

2010

Volltextzugriff (PDF)

Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation

Current Neurology and Neuroscience Reports, 2016-11, Vol.16 (11), p.98-98, Article 98

2016

Volltextzugriff (PDF)

Apical Ballooning Resulting from Limbic Encephalitis

The American journal of medicine, 2009-06, Vol.122 (6), p.583-586

2009

Volltextzugriff (PDF)

The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis

Autoimmune Diseases, 2011-01, Vol.2011 (2011), p.19-24

2011

Volltextzugriff (PDF)

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial

Multiple sclerosis journal - experimental, translational and clinical, 2019-04, Vol.5 (2), p.2055217319850193-2055217319850193

2019

Volltextzugriff (PDF)

GABA-A Receptor Meningoencephalitis presenting with New Onset Refractory Status Epilepticus and Reversible Vasculopathy (P4-5.002)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Dietary Interventions and Multiple Sclerosis

Current neurology and neuroscience reports, 2017-03, Vol.17 (3), p.28-28, Article 28

2017

Volltextzugriff (PDF)

Vascular Disease Risk Factors in Multiple Sclerosis (MS) is Associated with Brain Adenosine Triphosphate Abnormalities: Dysmetabolism May Drive MS Disease Progression (2398)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Iron Deficiency Is Commonly Observed in Female Multiple Sclerosis (MS) Patients with Relapsed/Refractory or Primary Progressive Disease Referred for Biological Therapies

Blood, 2022-11, Vol.140 (Supplement 1), p.11086-11087

2022

Volltextzugriff (PDF)

Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage

Neurology, 2020-03, Vol.94 (9)

2020

Volltextzugriff (PDF)

Effects of Vascular Disease Risk Factors on Brain ATP in People with Multiple Sclerosis—A 3-year Longitudinal Study (P11-6.010)

Neurology, 2024-04, Vol.102 (17_supplement_1)

2024

Volltextzugriff (PDF)

Experiences with a virtual nationwide seminar series for neuroimmunology trainees (P14-6.001)

Neurology, 2022-05, Vol.98 (18_supplement)

2022

Volltextzugriff (PDF)

Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: No

Multiple sclerosis, 2012-11, Vol.18 (11), p.1529-1530

2012

Volltextzugriff (PDF)

Clinical and Radiologic Features of a Cohort of Adult and Pediatric Patients in the Pacific Northwest with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (P13-5.022)

Neurology, 2023-04, Vol.100 (17_supplement_2)

2023

Volltextzugriff (PDF)

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study

Autoimmune Diseases, 2012-01, Vol.2012 (2012), p.523-533

2012

Volltextzugriff (PDF)

Complementary and Alternative Medical Therapies in Multiple Sclerosis—The American Academy of Neurology Guidelines: A Commentary : CURRENT AND EMERGING THERAPIES FOR MULTIPLE SCLEROSIS

Clinical therapeutics, 2014, Vol.36 (12), p.1972-1978

2014

Volltextzugriff (PDF)

The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis?

Neurology, 2011-02, Vol.76 (8), p.680-681

2011

Volltextzugriff (PDF)

Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology

Neurology, 2014-03, Vol.82 (12), p.1083-1092

2014

Volltextzugriff (PDF)

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

The New England journal of medicine, 2018-08, Vol.379 (9), p.846-855

2018

Volltextzugriff (PDF)

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study

Neurology, 2016-09, Vol.87 (13), p.1393-1399

2016

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(73)
Buchkapitel
(2)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rituximab for treatment of refractory multiple sclerosis relapses during pregnancy

A low-fat diet improves fatigue in multiple sclerosis: Results from a randomized controlled trial

Low-fat, plant-based diet in multiple sclerosis: A randomized controlled trial

Complementary and Alternative Medical Therapies in Multiple Sclerosis–The American Academy of Neurology Guidelines: A Commentary

Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling

Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation

Apical Ballooning Resulting from Limbic Encephalitis

The Effects of Omega-3 Fatty Acids on Matrix Metalloproteinase-9 Production and Cell Migration in Human Immune Cells: Implications for Multiple Sclerosis

Oral lipoic acid as a treatment for acute optic neuritis: a blinded, placebo controlled randomized trial

GABA-A Receptor Meningoencephalitis presenting with New Onset Refractory Status Epilepticus and Reversible Vasculopathy (P4-5.002)

Dietary Interventions and Multiple Sclerosis

Vascular Disease Risk Factors in Multiple Sclerosis (MS) is Associated with Brain Adenosine Triphosphate Abnormalities: Dysmetabolism May Drive MS Disease Progression (2398)

Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial

Iron Deficiency Is Commonly Observed in Female Multiple Sclerosis (MS) Patients with Relapsed/Refractory or Primary Progressive Disease Referred for Biological Therapies

Pearls & Oy-sters: Primary angiitis of the CNS presenting with recurrent intracranial hemorrhage

Effects of Vascular Disease Risk Factors on Brain ATP in People with Multiple Sclerosis—A 3-year Longitudinal Study (P11-6.010)

Experiences with a virtual nationwide seminar series for neuroimmunology trainees (P14-6.001)

Treat patients with radiologically isolated syndrome when the MRI brain scan shows dissemination in time: No

Clinical and Radiologic Features of a Cohort of Adult and Pediatric Patients in the Pacific Northwest with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) (P13-5.022)

Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study

Complementary and Alternative Medical Therapies in Multiple Sclerosis—The American Academy of Neurology Guidelines: A Commentary : CURRENT AND EMERGING THERAPIES FOR MULTIPLE SCLEROSIS

The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis?

Summary of evidence-based guideline: complementary and alternative medicine in multiple sclerosis: report of the guideline development subcommittee of the American Academy of Neurology

Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study

Suchergebnisse filtern